Stay updated on Efgartigimod in Post-COVID-19 POTS Clinical Trial

Sign up to get notified when there's something new on the Efgartigimod in Post-COVID-19 POTS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efgartigimod in Post-COVID-19 POTS Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision: v3.6.0 was added. Several study documents and metadata (PDFs, protocols, IPD plans, collaborators) were removed from the study record.
    Difference
    18%
    Check dated 2026-06-14T04:27:04.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.5.4 to v3.5.5, representing an internal software or content-management update. This does not alter the information presented about the study or its navigation.
    Difference
    0.0%
    Check dated 2026-06-06T23:32:19.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    Version label updated from v3.5.3 to v3.5.4, indicating a minor platform update. There are no evident changes to the study details or page content.
    Difference
    0.0%
    Check dated 2026-05-16T09:16:25.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page’s footer/version indicator was updated from **Revision: v3.5.2** to **Revision: v3.5.3**, reflecting a background site update rather than a change to the clinical trial information.
    Difference
    0.0%
    Check dated 2026-04-24T17:09:28.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-17T14:08:40.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    IQVIA Pty Ltd was added as a collaborator and Iqvia Pty Ltd was removed, correcting the sponsor/collaborator listing.
    Difference
    0.0%
    Check dated 2026-04-10T09:13:58.000Z thumbnail image

Stay in the know with updates to Efgartigimod in Post-COVID-19 POTS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efgartigimod in Post-COVID-19 POTS Clinical Trial page.